Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

IMPAVIDO Drug Profile

« Back to Dashboard
Impavido is a drug marketed by Knight Theraps and is included in one NDA. It is available from two suppliers.

The generic ingredient in IMPAVIDO is miltefosine. Two suppliers are listed for this compound. Additional details are available on the miltefosine profile page.

Summary for Tradename: IMPAVIDO

Suppliers / Packagers: see list2
Bulk Api Vendors: see list55
Clinical Trials: see list4
Patent Applications: see list2,912
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMPAVIDO at DailyMed

Pharmacology for Tradename: IMPAVIDO

Drug ClassAntileishmanial
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Knight Theraps
CAPSULE;ORAL204684-001Mar 19, 2014RXYesYes► subscribe► subscribe
Knight Theraps
CAPSULE;ORAL204684-001Mar 19, 2014RXYesYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.